Article Versions Notes

El-Kalyoubi S, El-Sebaey SA, Elfeky SM, AL-Ghulikah HA, El-Zoghbi MS. Novel Aminopyrimidine-2,4-diones, 2-Thiopyrimidine-4-ones, and 6-Arylpteridines as Dual-Target Inhibitors of BRD4/PLK1: Design, Synthesis, Cytotoxicity, and Computational Studies. Pharmaceuticals. 2023; 16(9):1303. https://doi.org/10.3390/ph16091303

El-Kalyoubi, Samar, Samiha A. El-Sebaey, Sherin M. Elfeky, Hanan A. AL-Ghulikah, and Mona S. El-Zoghbi. 2023. "Novel Aminopyrimidine-2,4-diones, 2-Thiopyrimidine-4-ones, and 6-Arylpteridines as Dual-Target Inhibitors of BRD4/PLK1: Design, Synthesis, Cytotoxicity, and Computational Studies" Pharmaceuticals 16, no. 9: 1303. https://doi.org/10.3390/ph16091303

El-Kalyoubi, S., El-Sebaey, S. A., Elfeky, S. M., AL-Ghulikah, H. A., & El-Zoghbi, M. S. (2023). Novel Aminopyrimidine-2,4-diones, 2-Thiopyrimidine-4-ones, and 6-Arylpteridines as Dual-Target Inhibitors of BRD4/PLK1: Design, Synthesis, Cytotoxicity, and Computational Studies. Pharmaceuticals, 16(9), 1303. https://doi.org/10.3390/ph16091303